Cargando…

Loeffler endocarditis as a rare cause of heart failure with preserved ejection fraction: A case report and review of literature

RATIONALE: Hypereosinophilic syndrome (HES) is a rare disease characterized by hypereosinophilia and its ensuing organ damage. Cardiac involvement is divided into 3 chronological stages: an acute necrotic stage; a thrombus formation stage; and a fibrotic stage. Infiltration of the myocardium by eosi...

Descripción completa

Detalles Bibliográficos
Autores principales:	Gao, Ming, Zhang, Weihua, Zhao, Waiou, Qin, Ling, Pei, Fei, Zheng, Yang
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Wolters Kluwer Health 2018
Materias:	3400
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5882404/ https://www.ncbi.nlm.nih.gov/pubmed/29538200 http://dx.doi.org/10.1097/MD.0000000000010079

Ejemplares similares

Loeffler Endocarditis Causing Heart Failure with Preserved Ejection Fraction (HFpEF): Characteristic Images and Diagnostic Pathway
por: Lupu, Silvia, et al.
Publicado: (2022)

Clinical significance of serum magnesium levels in patients with heart failure with preserved ejection fraction
por: Nishihara, Taiki, et al.
Publicado: (2019)

Heart rate and outcomes in patients with heart failure with preserved ejection fraction: A dose–response meta-analysis
por: Shang, Xiaoke, et al.
Publicado: (2017)

Left atrial diameter in heart failure with left ventricular preserved, mid-range, and reduced ejection fraction
por: Zhu, Ning, et al.
Publicado: (2019)

Iron therapy in iron-deficiency patients with heart failure with preserved ejection fraction: A protocol for meta-analysis
por: Fukuta, Hidekatsu, et al.
Publicado: (2021)

Sodium–glucose cotransporter 2 inhibitors in heart failure with preserved ejection fraction: A protocol for meta-analysis
por: Fukuta, Hidekatsu, et al.
Publicado: (2021)

Values of hemodynamic variation in response to passive leg raising in predicting exercise capacity of heart failure with preserved ejection fraction
por: Zhou, Hong-Lian, et al.
Publicado: (2016)

High-intensity interval training for heart failure with preserved ejection fraction: A protocol for systematic review and meta-analysis
por: Zhang, Sisi, et al.
Publicado: (2020)

Clinical characteristics and outcomes of patients hospitalized with heart failure with preserved ejection fraction and low NT-proBNP levels
por: Chen, Yu-Yi, et al.
Publicado: (2023)

SGLT2 inhibitors among patients with heart failure with preserved ejection fraction: A meta-analysis of randomised controlled trials
por: Jaiswal, Akash, et al.
Publicado: (2023)

Effectiveness and safety of Baduanjin exercise (BDJE) on heart failure with preserved left ventricular ejection fraction (HFpEF): A protocol for systematic review and meta-analysis
por: Chen, Mingtai, et al.
Publicado: (2020)

Effect of the angiotensin-receptor-neprilysin inhibitor in heart failure patients with left ventricular ejection fraction higher than 40%
por: Zhao, Mingyue, et al.
Publicado: (2019)

New pharmacological treatments for heart failure with reduced ejection fraction (HFrEF): A Bayesian network meta-analysis
por: Li, Heng, et al.
Publicado: (2020)

The association of hemodynamic markers of right ventricular dysfunction with SII index and clinical outcomes in reduced ejection fraction heart failure
por: Balci, Kevser, et al.
Publicado: (2023)

Efficacy and safety of sacubitril valsartan in treating heart failure with midrange ejection fraction after acute myocardial infarction in diabetic patients
por: Ye, Fanhao, et al.
Publicado: (2022)

Outcomes of guideline-based medical therapy in patients with acute heart failure and reduced left ventricular ejection fraction: Observations from the Gulf acute heart failure registry (Gulf CARE)
por: Jan, Reem K., et al.
Publicado: (2022)

Long-term effects of angiotensin receptor neprilysin inhibitor therapy in heart failure patients with reduced ejection fraction: A retrospective cohort study
por: Koçak, Ajar, et al.
Publicado: (2023)

Evaluation of the safety and efficacy of Zhenwu decoction as adjuvant therapy for the treatment of heart failure with reduced ejection fraction: A protocol for systematic review and meta-analysis
por: Han, Yue, et al.
Publicado: (2022)

Prognostic value of area of calcified aortic valve by 2-dimensional echocardiography in asymptomatic severe aortic stenosis patients with preserved left ventricular ejection fraction
por: Wu, Victor Chien-Chia, et al.
Publicado: (2018)

Heart failure with preserved ejection fraction
por: Rigolli, Marzia, et al.
Publicado: (2013)

Heart failure with preserved ejection fraction
por: ElGuindy, Ahmed, et al.
Publicado: (2012)

Successful Medical Management of a Rare Loeffler Endocarditis Case
por: Gulel, Okan, et al.
Publicado: (2018)

Case report: Different clinical manifestations of the rare Loeffler endocarditis
por: Zhao, Yuanyuan, et al.
Publicado: (2022)

Successful Treatment of Classical Loeffler's Endocarditis
por: Mohan, Nitin Chandra, et al.
Publicado: (2021)

Association of N-terminal pro-brain natriuretic peptide with contrast-induced acute kidney injury and long-term mortality in patients with heart failure and mid-range ejection fraction: An observation study
por: Wang, Kun, et al.
Publicado: (2017)

Loeffler endocarditis with intracardiac thrombus: case report and literature review
por: Zhang, Qian, et al.
Publicado: (2021)

Biomarkers in heart failure with preserved ejection fraction
por: Meijers, W. C., et al.
Publicado: (2016)

Management of heart failure with preserved ejection fraction
por: Gard, Emma, et al.
Publicado: (2020)

Managing heart failure with preserved ejection fraction
por: Davidson, Alexander, et al.
Publicado: (2020)

Biomarkers in Heart Failure with Preserved Ejection Fraction
por: Bayes-Genis, Antoni, et al.
Publicado: (2022)

Comorbidities in heart failure with preserved ejection fraction
por: Deichl, Andrea, et al.
Publicado: (2022)

Left atrial ejection fraction and outcomes in heart failure with preserved ejection fraction
por: Kanagala, Prathap, et al.
Publicado: (2019)

Therapeutic implications of statins in heart failure with reduced ejection fraction and heart failure with preserved ejection fraction: a review of current literature
por: Techorueangwiwat, Chol, et al.
Publicado: (2021)

Loeffler Endocarditis as a Manifestation of Paraneoplastic Hypereosinophilia
por: Kelley, Brian P., et al.
Publicado: (2020)

Loeffler's Endocarditis and the Diagnostic Utility of Multimodality Imaging
por: Afzal, Saira, et al.
Publicado: (2020)

Loeffler Endocarditis: A Manifestation of Hypereosinophilic Syndrome
por: Arustamyan, Michael, et al.
Publicado: (2019)

Hypereosinophilic Syndrome with Advanced-Stage Loeffler Endocarditis
por: Dzelebdzic, Sanja, et al.
Publicado: (2022)

A Rare Case of Pulmonary Artery Dissection Associated With Infective Endocarditis
por: Shi, Xiaoqing, et al.
Publicado: (2016)

Cardiorenal Syndrome Caused by Heart Failure with Preserved Ejection Fraction
por: Lazzeri, Chiara, et al.
Publicado: (2011)

Prognostic Value of Anxiety Between Heart Failure With Reduced Ejection Fraction and Heart Failure With Preserved Ejection Fraction
por: Lin, Tin‐Kwang, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_qec12uidaof2k0o5nlnmc685vn